Benjamin Frishberg

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Botulinum Toxin Type A (BOTOX ^® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Ninan T. Mathew, Benjamin Frishberg, Marek Gawel et al. · Headache The Journal of Head and Face Pain · 2005 · 265 citations

Medicine, Neurology, Pharmacotherapy +17

Cell Therapy for Chronic TBI

Masahito Kawabori, Alan Weintraub, Hideaki Imai et al. · Neurology · 2021 · 82 citations · Full text

Medicine, Neuroscience, Neurosurgery +17